Conversely, it was suggested that ACE2 has the potential of slowing the progression of experimental diabetic chronic kidney disease [11], and it was found to be highly and significantly expressed in the kidney among individuals with chronic kidney diseases or DN [12]. The gene discussed is ACE2; the disease is chronic kidney disease.